Bio Plus Co., Ltd (KOSDAQ:099430)

Market Cap	357.55B
Revenue (ttm)	96.80B
Net Income (ttm)	16.05B
Shares Out	61.54M
EPS (ttm)	237.82
PE Ratio	24.43
Forward PE	n/a
Dividend	50.00 (0.87%)
Ex-Dividend Date	Dec 29, 2025

Volume	420,706
Average Volume	483,202
Open	5,820.00
Previous Close	5,810.00
Day's Range	5,650.00 - 5,840.00
52-Week Range	5,150.00 - 8,420.00
Beta	0.54
RSI	46.76
Earnings Date	Nov 14, 2025

About Bio Plus

Bio Plus Co., Ltd engages in the research and development, production, and sale of bio products in South Korea. It offers dermal fillers under the SkinPlus – Hyal, Bio+ Dew, HyalDew, DeneB Classic, Stilea, and 3-Senses brand names. The company also provides medical products, including InterBlock, an absorbable anti-adhesion barrier; Synofil, a synovial fluid replacement; and Blad-Care, a solution to temporarily improve cystitis symptoms. In addition, it offers mesotherapy products, such as skin rejuvenation products under the Kiara Reju name; S...

• Industry: Surgical and Medical Instruments and Apparatus
• Founded: 2003
• Employees: 147
• Stock Exchange: KOSDAQ
• Ticker Symbol: 099430

Financial Performance

In 2024, Bio Plus's revenue was 66.41 billion, an increase of 2.10% compared to the previous year's 65.04 billion. Earnings were 14.15 billion, a decrease of -44.68%.